Human therapeutic antibodies constitute the industry’s fastest-growing therapeutic class. In the US, more than 500 antibodies are in various stages of clinical development, and the number of ...

The key to developing such therapies is access to the broadest possible repertoire of human antibodies to rapidly screen them for binders to the pathogenic antigens of interest. Sorrento’s ...

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

View Full Profile. Learn about our Editorial Policies. For decades, researchers fixated on the extraordinary potential nestled within the human immune system, particularly the formidable prowess of ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

Nevertheless, the team believes these engineered antibody candidates could aid in developing effective human-derived antivenom against Latrodectus species, weaving a new web of hope for black widow ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

Researchers have a new hope for preventing severe illness from the bird flu after finding a groundbreaking antibody treatment ...

This greatly expedited the process of therapeutic antibody development. CDD-H52Wa HEK293 Human CD3 epsilon&CD3 delta Heterodimer Protein, Fc, His Tag&Fc, Flag Tag (MALS verified) Hot CDD-H82W6 ...

"We are delighted to partner with Windward Bio to advance the development of HBM9378/SKB378, a promising TSLP-targeted fully human antibody with significant potential to address immunological diseases ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.